Artificial intelligence is rapidly transforming healthcare and its potential to improve breast cancer screening is now being explored by researchers at UMass Chan Medical School. A new AI-driven tool aims to identify women at higher risk of developing breast cancer, potentially detecting cancers that might be missed by standard mammograms – a critical step in improving outcomes for this prevalent disease.
Breast cancer remains one of the most commonly diagnosed cancers among women in the United States, according to the American Cancer Society. Early detection is widely recognized as key to successful treatment. While mammography is currently the standard screening method, it has limitations, particularly for women with dense breast tissue, where identifying tumors can be more challenging.
Researchers Mohammed Salman Shazeeb, PhD, associate professor of radiology, and Gopal Vijayaraghavan, MD, MPH, professor of radiology, are collaborating with investigators at the Massachusetts Institute of Technology to test an AI-based risk assessment model. The project is supported by grants from state agencies and the Breast Cancer Research Foundation. This tool analyzes routine screening mammograms and generates a risk score, estimating a woman’s likelihood of developing breast cancer within the next few years.
Targeted Screening with AI Risk Scores
Rather than recommending supplemental imaging for all patients, the AI risk score helps identify a smaller group of women who could benefit most from additional testing. “Among the roughly 6 to 7 percent of women who scored above our risk threshold, we invited them for contrast-enhanced breast MRI,” explained Dr. Shazeeb. “What’s striking is that all had normal screening mammograms, yet MRI found cancers in some of them that we would otherwise have missed.”
In an initial study of 145 participants, MRI detected four additional cancers despite negative mammography results – a significantly higher yield than typically observed with mammography screening alone in a comparable group of women. This suggests the AI model is effectively pinpointing individuals who require further investigation.
How AI Enhances Cancer Detection
“MRI remains the gold standard for detecting many breast cancers,” said Dr. Vijayaraghavan. “But it’s expensive, time-consuming and not feasible for everyone annually. A tool that helps us focus those resources on women at highest risk could build early detection more efficient and more personalized.”
AI models excel at detecting subtle imaging features that may be imperceptible to the human eye, leveraging patterns learned from extensive datasets. This ability to recognize nuanced signals is a key advantage in identifying potential risks. “The AI can process many more features on an image than a radiologist can visually,” Vijayaraghavan explained. “But it doesn’t think the way a physician does. The tool is trained for performance, not understanding. That’s why these tools are designed to augment, not replace, clinical judgment.”
Human oversight remains crucial for interpreting the AI’s findings and ensuring that insignificant results are not flagged. Ongoing research focuses on optimizing the balance between sensitivity and specificity, and larger studies are needed to validate the tool’s performance across diverse populations.
Challenges and Future Directions
While the initial results are promising, several hurdles remain before AI-guided risk assessment can become standard clinical practice. These include obtaining FDA approval, establishing appropriate reimbursement policies, and ensuring equitable access to the technology. “Before this can be widely applied, we need larger-scale validation and real-world implementation data,” Shazeeb said. “We also have to ensure that it works fairly across diverse populations and different mammography systems.”
Patient engagement is also a key consideration. Sara Schiller, senior research program manager in the Department of Radiology, noted that “Many women I speak with just want to help further research and are not hesitant about AI per se. Many have family histories of breast cancer and are eager to contribute.”
A Personalized Approach to Breast Cancer Screening
Experts emphasize that AI is not a replacement for existing screening methods, but rather a powerful tool that can help tailor screening to individual risk profiles. “The goal isn’t to replace mammograms,” said Vijayaraghavan. “It’s to add another layer of insight, a decision support tool, that helps us find cancers earlier, when treatment is more effective and less invasive.”
As research progresses, tools like this have the potential to usher in a more personalized approach to breast cancer screening, combining the latest technology with clinical expertise to improve outcomes for women. The continued development and validation of AI-driven risk assessment models represent a significant step forward in the fight against breast cancer.
Disclaimer: This information is intended for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
What are your thoughts on the role of AI in healthcare? Share your comments below, and let’s continue the conversation.
